Medical cannabis patients showed no cognitive impairment 4 hours after THC use across all studies reviewed

Across all seven included studies, cognitive performance declined mostly in a THC dose-dependent manner with steady resolution in the hours following administration. In every study, there was no difference between any THC group and placebo on any neurocognitive measure after 4 hours of recovery. THC doses were lower than those typically used in recreational studies.

Systematic search of MEDLINE and EMBASE (2000-2019) for controlled trials of medical cannabis patients with chronic non-cancer pain or spasticity. After screening 37 full-text articles, seven met inclusion criteria: six RCTs and one observational clinical trial. Qualitative synthesis of neurocognitive testing results.

Medical cannabis patients need practical guidance on when it is safe to drive or perform safety-sensitive tasks. This review provides the first focused evidence that 4 hours may be a reasonable minimum recovery window after medical-dose THC.

The 4-hour recovery finding provides a starting point for clinical guidance, though individual variability, tolerance effects, and the use of higher-potency products could shift this timeline. The distinction between medical and recreational cannabis doses is critical.

Only seven studies met criteria, limiting generalizability. Studies used variable neurocognitive tests and assessment timing. Medical cannabis patients may develop tolerance that shortens impairment duration. Does not address chronic cognitive effects of ongoing use.